Oxylipins in general, as bioactive signaling lipids, are increasingly being associated with inflammation, vascular permeability, and cardiovascular disease as well as diabetes, obesity-induced hypertriglyceridemia, and insulin signaling23,33–36. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.